Adaptive Biotechnologies Stock Rises On Plan To Split MRD, Immune Medicine Businesses - Adaptive Biotechn

Adaptive Biotechnologies plans to separate its businesses as clonoSEQ profitability and revenue growth accelerate.

Raccontata dabenzinga.com